S
SeqOne Genomics
Smarter genomics, faster insights, greater confidence
Montpellier, France
100+
About SeqOne Genomics
Industry:
Clinical Genomics / Bioinformatics SaaS
Founded:
2017
Founders:
Nicolas Philippe, Guillaume Buwalda, Jean-Marc Holder
Status:
Private
Funding & Growth
Total Raised:
€30M+
Stage:
Series A
Key Investors:
Supernova Invest
Elaia
Omnes Capital
Mérieux Equity Partners
✓ Pros
- • Clinical-grade genomics SaaS with a regulatory focus
- • Used by 1,000+ geneticists across 30+ countries
- • Backed by Elaia, Omnes and Mérieux
- • Strong bioinformatics + software culture
✗ Cons
- • Smaller scale-up (~100 people)
- • Diagnostics regulatory overhead
- • Mostly France/Europe footprint
🧬 Bioinformatics Focus
SeqOne builds an AI-powered NGS bioinformatics platform used by clinical and research labs to analyze and interpret genomic data.
Its tools — from the SeqOne Flow pipeline to the DiagAI variant-prioritization score and automated HRD testing — turn raw sequencing data into clinical-grade reports.
Founded in Montpellier in 2017, its team spans bioinformatics, data science, software and regulatory/QA.